These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 23472056)

  • 41. Spread of artemisinin-resistant Plasmodium falciparum in Myanmar: a cross-sectional survey of the K13 molecular marker.
    Tun KM; Imwong M; Lwin KM; Win AA; Hlaing TM; Hlaing T; Lin K; Kyaw MP; Plewes K; Faiz MA; Dhorda M; Cheah PY; Pukrittayakamee S; Ashley EA; Anderson TJ; Nair S; McDew-White M; Flegg JA; Grist EP; Guerin P; Maude RJ; Smithuis F; Dondorp AM; Day NP; Nosten F; White NJ; Woodrow CJ
    Lancet Infect Dis; 2015 Apr; 15(4):415-21. PubMed ID: 25704894
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Combined antimalarial therapy using artemisinin].
    Majori G
    Parassitologia; 2004 Jun; 46(1-2):85-7. PubMed ID: 15305693
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Artesunate and mefloquine given simultaneously for three days via a prepacked blister is equally effective and tolerated as a standard sequential treatment of uncomplicated acute Plasmodium falciparum malaria: randomized, double-blind study in Thailand.
    Krudsood S; Looareesuwan S; Silachamroon U; Chalermrut K; Pittrow D; Cambon N; Mueller EA
    Am J Trop Med Hyg; 2002 Nov; 67(5):465-72. PubMed ID: 12479545
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Four Artemisinin-Based Treatments in African Pregnant Women with Malaria.
    ; Pekyi D; Ampromfi AA; Tinto H; Traoré-Coulibaly M; Tahita MC; Valéa I; Mwapasa V; Kalilani-Phiri L; Kalanda G; Madanitsa M; Ravinetto R; Mutabingwa T; Gbekor P; Tagbor H; Antwi G; Menten J; De Crop M; Claeys Y; Schurmans C; Van Overmeir C; Thriemer K; Van Geertruyden JP; D'Alessandro U; Nambozi M; Mulenga M; Hachizovu S; Kabuya JB; Mulenga J
    N Engl J Med; 2016 Mar; 374(10):913-27. PubMed ID: 26962727
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy and Safety of Pyronaridine-Artesunate for the Treatment of Uncomplicated
    Han KT; Lin K; Han ZY; Myint MK; Aye KH; Thi A; Thapa B; Bustos MD; Borghini-Fuhrer I; Ringwald P; Duparc S
    Am J Trop Med Hyg; 2020 Sep; 103(3):1088-1093. PubMed ID: 32524960
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Compliance with a 2 day course of artemether-mefloquine in an area of highly multi-drug resistant Plasmodium falciparum malaria.
    Na-Bangchang K; Congpuong K; Sirichaisinthop J; Suprakorb K; Karbwang J
    Br J Clin Pharmacol; 1997 Jun; 43(6):639-42. PubMed ID: 9205825
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro susceptibility of Plasmodium falciparum isolates from Myanmar to antimalarial drugs.
    Wongsrichanalai C; Lin K; Pang LW; Faiz MA; Noedl H; Wimonwattrawatee T; Laoboonchai A; Kawamoto F
    Am J Trop Med Hyg; 2001 Nov; 65(5):450-5. PubMed ID: 11716097
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Artemisinin derivatives and malaria: useful, in combination with other antimalarials.
    Prescrire Int; 2008 Aug; 17(96):162-8. PubMed ID: 19492494
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy of Artequick versus artesunate-mefloquine in the treatment of acute uncomplicated falciparum malaria in Thailand.
    Tangpukdee N; Krudsood S; Thanachartwet V; Pengruksa C; Phophak N; Kano S; Li G; Brittenham GM; Looareesuwan S; Wilairatana P
    Southeast Asian J Trop Med Public Health; 2008 Jan; 39(1):1-8. PubMed ID: 18567436
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Defining the in vivo phenotype of artemisinin-resistant falciparum malaria: a modelling approach.
    White LJ; Flegg JA; Phyo AP; Wiladpai-ngern JH; Bethell D; Plowe C; Anderson T; Nkhoma S; Nair S; Tripura R; Stepniewska K; Pan-Ngum W; Silamut K; Cooper BS; Lubell Y; Ashley EA; Nguon C; Nosten F; White NJ; Dondorp AM
    PLoS Med; 2015 Apr; 12(4):e1001823. PubMed ID: 25919029
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pyronaridine-artesunate versus mefloquine plus artesunate for malaria.
    Rueangweerayut R; Phyo AP; Uthaisin C; Poravuth Y; Binh TQ; Tinto H; Pénali LK; Valecha N; Tien NT; Abdulla S; Borghini-Fuhrer I; Duparc S; Shin CS; Fleckenstein L;
    N Engl J Med; 2012 Apr; 366(14):1298-309. PubMed ID: 22475593
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Monitoring for Plasmodium falciparum drug resistance to artemisinin and artesunate in Binh Phuoc Province, Vietnam: 1998-2009.
    Thanh NV; Toan TQ; Cowman AF; Casey GJ; Phuc BQ; Tien NT; Hung NM; Biggs BA
    Malar J; 2010 Jun; 9():181. PubMed ID: 20573274
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of chloroquine, sulfadoxine/pyrimethamine, mefloquine and mefloquine-artesunate for the treatment of falciparum malaria in Kachin State, North Myanmar.
    Smithuis F; Shahmanesh M; Kyaw MK; Savran O; Lwin S; White NJ
    Trop Med Int Health; 2004 Nov; 9(11):1184-90. PubMed ID: 15548314
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Randomized comparison of mefloquine-artesunate versus quinine in the treatment of multidrug-resistant falciparum malaria in pregnancy.
    McGready R; Brockman A; Cho T; Cho D; van Vugt M; Luxemburger C; Chongsuphajaisiddhi T; White NJ; Nosten F
    Trans R Soc Trop Med Hyg; 2000; 94(6):689-93. PubMed ID: 11198658
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genetic polymorphisms of candidate markers and in vitro susceptibility of Plasmodium falciparum isolates from Thai-Myanmar border in relation to clinical response to artesunate-mefloquine combination.
    Phompradit P; Muhamad P; Chaijaroenkul W; Na-Bangchang K
    Acta Trop; 2014 Nov; 139():77-83. PubMed ID: 25004442
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pfmdr1 and in vivo resistance to artesunate-mefloquine in falciparum malaria on the Cambodian-Thai border.
    Alker AP; Lim P; Sem R; Shah NK; Yi P; Bouth DM; Tsuyuoka R; Maguire JD; Fandeur T; Ariey F; Wongsrichanalai C; Meshnick SR
    Am J Trop Med Hyg; 2007 Apr; 76(4):641-7. PubMed ID: 17426163
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Primaquine for reducing Plasmodium falciparum transmission.
    Graves PM; Gelband H; Garner P
    Cochrane Database Syst Rev; 2012 Sep; (9):CD008152. PubMed ID: 22972117
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Respondent-driven sampling on the Thailand-Cambodia border. I. Can malaria cases be contained in mobile migrant workers?
    Khamsiriwatchara A; Wangroongsarb P; Thwing J; Eliades J; Satimai W; Delacollette C; Kaewkungwal J
    Malar J; 2011 May; 10():120. PubMed ID: 21554744
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cellular mechanisms of action and resistance of Plasmodium falciparum to artemisinin.
    Phompradit P; Chaijaroenkul W; Na-Bangchang K
    Parasitol Res; 2017 Dec; 116(12):3331-3339. PubMed ID: 29127525
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ex vivo piperaquine resistance developed rapidly in Plasmodium falciparum isolates in northern Cambodia compared to Thailand.
    Chaorattanakawee S; Lon C; Jongsakul K; Gawee J; Sok S; Sundrakes S; Kong N; Thamnurak C; Chann S; Chattrakarn S; Praditpol C; Buathong N; Uthaimongkol N; Smith P; Sirisopana N; Huy R; Prom S; Fukuda MM; Bethell D; Walsh DS; Lanteri C; Saunders D
    Malar J; 2016 Oct; 15(1):519. PubMed ID: 27769299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.